# Multiple-Ascending Dose Study

> **NCT00892840** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 57 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** BMS-820836
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00892840
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2011-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00892840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00892840, "Multiple-Ascending Dose Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00892840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*